should i force myself to eat on semaglutide What Semaglutide: Complete Dietary Guide Do You Have to Eat

Improving vasomotor symptoms

A change in FDA leadership, new safety requirements, or shifts in regulatory philosophy could add review time

Then the dominoes: the LIFT-AD trial failed in September 2024, the Department of Justice settlement landed in January 2025, and the formal retractions of two foundational papers followed in April 2025

Our medical team recognizes the potential of GLP-1 medications to help patients achieve sustainable weight loss and improved metabolic health

Observational study of kidney function and albuminuria in patients with type 2 diabetes treated with exenatide BID versus insulin glargine

By reducing inflammation, improving blood sugar control, and targeting brain regions linked to addiction, GLP-1 agonists address root causes of multiple health issues